patent/MA-37940-B1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MA-37940-B1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate	2013-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d916a76c3ba6aadad99a1ac99867d35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1f8a369915641529fb573156f80434c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e698493b7081e0866d522a049b201ae9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9596d1be459159076c9bf6e6c84f1aec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_671a37bb9c7033d32ba7ee2e594cd752 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_169534ec847c0a19a7e8402e16b0abbe
publicationDate	2018-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	MA-37940-B1
titleOfInvention	Octahydro-cyclopenta (c) pyrrole derivatives substituted for autotaxin inhibitors, useful for treating renal, hepatic and inflammatory conditions, nervous system disorders, fibrotic diseases.
abstract	The invention relates to novel compounds having the general formula (i) which are useful for treating renal diseases, hepatic, inflammatory, nervous system, fibrotic disorders, acute and chronic organ transplant rejection, respiratory system, vascular and cardiovascular diseases, cancer, ocular disorders, metabolic disorders, cholestatic and chronic pruritus
priorityDate	2012-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415814035 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID110688 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5168 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID532663 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID84050 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18606

Total number of triples: 35.